CLL/SLL Malignancy Clinical Trial Investigating Vaccine Effectiveness
Researchers at the National Institutes of Health (NIH) are seeking volunteers with CLL/SLL to participate in a vaccines study with FDA-approved and/or FDA-authorized vaccines. Volunteers will participate in the study for 6 months.
You May Be Eligible for the Study, if You
- Are at least 18 years old
- Have a diagnosis of Chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), AND
- Are currently receiving treatment for your CLL/SLL (e.g. ibrutinib, acalabrutinib or venetoclax)
- Have not received IVIG (intravenous immunoglobulin) in the past 3 months
- Have not received anti-CD20 and/or anti-CD19 antibody therapy in the past 6 months
- Have not previously received an allogeneic stem cell transplant
The NIH Clinical Center, America's Research Hospital located in Bethesda, MD.
Metro red line (Medical Center stop).
For More Information
NIH Clinical Center Office of Patient Recruitment
800-411-1222
TTY users dial 7-1-1
Email: ccopr@nih.gov
Or go online
Refer to study #000444-H
Department of Health and Human Services
National Institutes of Health Clinical Center (CC)
National Heart, Lung and Blood Institute (NHLBI)